Pengaruh Pemberian Variasi Dosis Rifampisin Terhadap Kadar Gamma Glutamyl Transferase dan Alkaline Phosphatase Pada Tikus Putih Galur Wistar

Authors

  • Sofiana Agustin Jeharu Program Studi Teknologi Laboratorium Medik, Universitas Bali Internasional
  • I Gusti Putu Agus Ferry Sutrisna Putra Program Studi Teknologi Laboratorium Medik, Universitas Bali Internasional
  • Ni Putu Widayanti Program Studi Teknologi Laboratorium Medik, Universitas Bali Internasional

Keywords:

Tuberculosis, Rifampicin, GGT and ALP levels

Abstract

Background: Tuberculosis is a contagious infectious disease caused by the bacterium Mycobacterium tuberculosis. Rifampicin is a first-line drug for the treatment of tuberculosis. Rifampicin has a bactericidal effect and the sterilizing effect is effective against intracellular and extracellular tuberculosis bacteria. In addition, one of the side effects of using rifampicin is hepatotoxicity. Objective: to determine the effect of rifampicin drug dosage on GGT and ALP levels in wistar rats. Methods: using an experimental study design with the pretest and posttest control group design method with the use of test animals 24 wistar rats divided into 4 groups. The technique of analyzing data using SPSS One Way Annova was followed by a Post-Hoc Test. Results: The results of the study showed an average increase in GGT levels in treatment groups 1, 2 and 3 was 29.5%, 40.9% and 55.4% and the mean increase in ALP levels in treatment groups 1, 2 and 3 was 27.5 %, 46.7% and 53.5%. The One Way ANOVA test results obtained p = 0.00 (p <0.05) followed by the Post Hoc test obtained α> 0.05. Conclusions: there was a significant effect on the levels of GGT and ALP after the administration of dose variations of the rifampicin drug in wistar strain white rats.

References

Akbar, Nurul. 2007. Diagnostik Hepatitis Akut dan Kronis. Jakarta: Bagian Ilmu Penyakit Dalam FKUI/RSCM.

Annisa, Rafika, Zarfiardy Aksa, dan Fauzi Fridayenti. 2015. “Perbedaan Kadar SGPT Pada Pasien Tuberkulosis Paru Sebelum dan Sesudah Fase Intensif di Poliklinik Paru Rsud Arifin Achmad Pekanbaru.” Jurnal Online Mahasiswa Fakultas Kedokteran Universitas Riau 2 (2): 1–10. https://jom.unri.ac.id/index.php/JOMFDOK/article/view/7204.

Baron, DN. 1995. Patologi Klinik. 4 ed. Jakarta: EGC.

Davoudi, SM. 2013. “Study of Hepatic Problems in Livestock.” European Journal of Zoological Research 2: 124–32. https://www.semanticscholar.org/paper/Study-of-Hepatic-Problems-in-livestock-Davoudi/a84ce1e71083e155998d2735bbc015031e414513.

Departemen Kesehatan Republik Indonesia. 2018. “Infodatin Tuberkulosis 2018.” Jakarta. https://pusdatin.kemkes.go.id/article/view/18101500001/infodatin-tuberkulosis-2018.html.

Departemen Kesehatan RI. 2008. “Profil Kesehatan Indonesia 2007.” Jakarta. https://pusdatin.kemkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/profil-kesehatan-indonesia-2007.pdf.

Ganong, W, dan SJ McPhee. 2011. Patofisiologi Penyakit: Pengantar Menuju Kedokteran Klinis. Jakarta: EGC.

Haurissa, Andreas Erick. 2014. “Gamma Glutamyl Transferase Sebagai Biomarker Risiko Penyakit Kardiovaskuler’.” Cermin Dunia Kedokteran 41: 816–18.

Julita S, Intan. 2012. “Aspek Farmakokinetik Beberapa Obat Berpotensi Hepatotoksik Pada Pasien Rawat Inap Di Bangsal Paru RSUD DR M Djamil Padang Periode Oktober 2011 Januari 2012.” Padang: Universitas Andalas. http://katalog.pustaka.unand.ac.id//index.php?p=show_detail&id=59869.

Kesehatan, Departemen. 2010. Pedoman Nasional Penanggulangan Tuberkulosis. 2 ed. Jakrta: Gerdunas TB.

Kwara, A, TP Flanigan, dan EJ Carter. 2005. “Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.” International Journal of Tuberculosis and Lung Disease (IJTLD) 8 (3): 248–57. https://pubmed.ncbi.nlm.nih.gov/15786886/.

Lian, Yong, Jing Zhao, Peiyu Xu, Yimei Wang, Jun Zhao, Li Jia, Ze Fu, Li Jing, Gang Liu, dan Shuangqing Peng. 2013. “Protective Effects of Metallothionein on Isoniazid and Rifampicin-Induced Hepatotoxicity in Mice.” PLoS ONE. https://doi.org/10.1371/journal.pone.0072058.

Murray, RK, DK Granner, dan WV Ropdwell. 2009. Biokimia Harper. 27 ed. Jakarta: EGC.

North-Lewis, P. 2008. Drugs and The Liver. London: Pharmatical Press.

Panjaitan, Ruqiah Ganda Putri, Ekowati Handharyani, Chairul Chairul, Masriani Masriani, Zulfa Zakiah, dan Wasmen Manalu. 2010. “The Effects of Carbon Tetrachloride Administration on Liver and Renal Function.” Makara Journal of Health Research 11 (1). https://doi.org/10.7454/msk.v11i1.217.

Purnamasari, Prihartini. 2008. “Pengaruh Pemberian Teh Hijau Terhadap Kadar Enzim Gamma Glutamyl Transferase Serum Tikus Wistar Yang Diberi Kloramfenikol - Diponegoro University | Institutional Repository (UNDIP-IR).” Semarang: Universitas Diponegoro. http://eprints.undip.ac.id/23940/.

Rosida, Azma. 2016. “Pemeriksaan Laboratorium Penyakit Hati.” Berkala Kedokteran 12 (1): 123. https://doi.org/10.20527/jbk.v12i1.364.

Sampurno, Ondri Dwi. 2016. “Tinjauan Farmakogenomik Rifampisin Dalam Pengobatan Tuberkulosis Paru.” Jurnal Biotek Medisiana Indonesia 4 (2): 59–70. https://doi.org/10.22435/jbmi.v4i2.5126.59-70.

Sanofi. 2019. “Product Monograph Rifadin.” Quebec.

Sari, Ida Diana, Yuyun Yuniar, dan Muhamad Syaripuddin. 2014. “Studi Monitoring Efek Samping Obat Antituberkulosis FDC Kategori 1 di Provinsi Banten dan Provinsi Jawa Barat.” Media Penelitian dan Pengembangan Kesehatan 24 (1): 28–35. https://doi.org/10.22435/mpk.v24i1.3484.28-35.

Tassaduq, I, S A Butt, dan S Hamid. 2011. “Protective effect of ascorbic acid on rifampicin induced hepatotoxicity in mice.” J Rawalpiindi Med Coll 15: 102–3.

Timbrell, John A. 2008. Principles of Biochemical Toxicology. Principles of Biochemical Toxicology. https://doi.org/10.3109/9781420007084.

WHO. 2018. Global tuberculosis report 2018. Geneva: World Health Organization; 2018. WHO Publication. https://doi.org/WHO/HTM/TB/2017.23.

Downloads

Published

2020-08-31